M. I. Demartis

Activation of v‐Myb avian myeloblastosis viral oncogene homolog‐like2 (MYBL2)‐LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53

D. Calvisi, M. Evert, S. Ladu, 2011, Hepatology.

Connective tissue growth factor autocriny in human hepatocellular carcinoma: Oncogenic role and regulation by epidermal growth factor receptor/yes‐associated protein–mediated activation

R. Urtasun, J. Prieto, M. Avila, 2011, Hepatology.

Role of transcriptional and posttranscriptional regulation of methionine adenosyltransferases in liver cancer progression

D. Calvisi, T. Ushijima, S. Yamashita, 2012, Hepatology.

Enzyme Biosensors for Biomedical Applications: Strategies for Safeguarding Analytical Performances in Biological Fluids

Angela Spanu, Gaia Rocchitta, Pier Andrea Serra, 2016, Sensors.

Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease

D. Calvisi, M. Ávila, C. Berasain, 2016, Oncotarget.

Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver

D. Calvisi, J. Calderaro, Xin Chen, 2015, Oncotarget.

Activated mutant forms of PIK3CA cooperate with RasV12 or c‐Met to induce liver tumour formation in mice via AKT2/mTORC1 cascade

D. Calvisi, Xin Chen, J. Tao, 2016, Liver international : official journal of the International Association for the Study of the Liver.

An expression signature of phenotypic resistance to hepatocellular carcinoma identified by cross-species gene expression analysis

Ju-Seog Lee, G. Solinas, M. Tomasi, 2012, Cellular Oncology.

Activation of v‐Myb avian myeloblastosis viral oncogene homolog‐like2 (MYBL2)‐LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53

D. Calvisi, M. Evert, S. Ladu, 2011, Hepatology.